Kayentis Offers Carbon-Neutral eCOA Suggestions
Kayentis, a global provider of eCOA solutions for clinical trials headquartered in France, has announced the launch of a set of initiatives to evaluate the carbon footprint of each clinical trial services eCOA component it conducts and propose solutions to clients on limiting the CO2 emissions of these eCOA projects.
Guillaume Juge, CEO of Kayentis. “While the solutions to reduce the impact of carbon emissions require closer collaboration with our customers, they have no impact on the cost of the study, nor will they lessen the quality or timeliness of the service we provide.” Some eCOA options, depending on the protocol include:
- A webCOA back-up strategy, using an online platform to directly enter patient data rather than stockpile spare devices on each site, or even centralize them at the country level
- Replacing onsite training and face-to-face meetings with virtual ones
- Using refurbished devices - as the lifespan of a device is around four years, refurbishing is a feasible solution for both short-term studies and to replace a device during the course of a study
For more information click here.
Including Women of Childbearing Age in Clinical Research
March 26th 2024In recognition of International Women's Month, we're featuring this recent talk between Associate Editor Miranda Schmalfuhs and Marie Teil, Global Head of UCB’s Women of Childbearing Age Program. They speak about the specific challenges women with chronic illnesses face when accessing appropriate treatment and participating in clinical trials, UCB's Women of Childbearing Age Program and it’s most successful strategies, and much more.
Using Patient Reported Outcomes in Dermatology Trials
April 25th 2024In part 3 of this video interview with ACT editor Andy Studna, Melissa Mooney, director, eCOA sales engineering, IQVIA sheds light on the unique challenges of dermatology trials and how clinical outcome assessments can be implemented in them.
Improving Engagement While Maintaining Data Integrity & Validity
March 19th 2024In recognition of Women's Health Month, we're featuring this recent talk between Associate Editor Miranda Schmalfuhs and uMotif's Chief Product Officer, Julia Lakeland, discuss new technologies improving patient engagement and reducing the emotional and logistical burdens of participation, ethical considerations that should be addressed when implementing those technologies, while ensuring patient privacy, and much more.
